ONCOGRAM: study protocol for the evaluation of therapeutic response and survival of metastatic colorectal cancer patients treated according to the guidelines of a chemosensitivity assay, the Oncogramme®

BACKGROUND: Colorectal cancer is a major public concern, being the second deadliest cancer in the world. Whereas survival is high for localized forms, metastatic colorectal cancer has showed poor prognosis, with a 5-year survival barely surpassing 11%. Conventional chemotherapies against this diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathonnet, Muriel, Vanderstraete, Mathieu, Bounaix Morand du Puch, Christophe, Giraud, Stéphanie, Lautrette, Christophe, Ouaissi, Mehdi, Tabchouri, Nicolas, Taïbi, Abdelkader, Martin, Renaud, Herafa, Isabelle, Tchalla, Achille, Christou, Niki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379769/
https://www.ncbi.nlm.nih.gov/pubmed/34419125
http://dx.doi.org/10.1186/s13063-021-05531-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379769/
https://www.ncbi.nlm.nih.gov/pubmed/34419125
http://dx.doi.org/10.1186/s13063-021-05531-y

Ejemplares similares